Browse our UCP2 Proteins (UCP2)

Zebrafish Uncoupling Protein 2 (Mitochondrial, Proton Carrier) (UCP2) interaction partners

1. except for reduced lipid peroxidation, we did not observe any significant reactive oxygen species reduction associated with increased Ucp2 activation in cold-exposed group.

Arabidopsis thaliana Uncoupling Protein 2 (Mitochondrial, Proton Carrier) (UCP2) interaction partners

1. AtUCP1 and AtUCP2 are the first reported mitochondrial carriers in Arabidopsis to transport aspartate and glutamate

Human Uncoupling Protein 2 (Mitochondrial, Proton Carrier) (UCP2) interaction partners

1. Studied energy expenditure as well as expression of uncoupling protein 2 (UCP2) in skeletal muscle of obese subjects participating in caloric restriction studies.

2. PEDF was demonstrated to increase UCP2 gene expression in ARPE19 cells.

3. UCP2 (G-866A) polymorphism may play a crucial role in the pathogenesis of insulin secretion thus leads to the development of type 2 diabetes.

4. UCP2 is mainly localized in proximal convoluted tubule cells, which may explain their relative propensity to damage in pathological conditions including the hypertensive disease.

5. tests variants in the UCP2 gene and diabetic retinopathy (DR) in Han Chinese with Type 2 Diabetes. Logistic regression analysis showed that the AA and GA genotypes of rs659366 were significantly associated with an increased risk for nonproliferative DR. Patients harboring the II and DI genotypes had a higher risk for proliferative DR in the codominant model and the DI genotype showed a higher risk for Non Proliferative DR

6. Polymorphism of Ala55Val UCP2 genotype in the male group showed that TT genotype and T allele significantly lowers the risk of obesity. Insertion/deletion of 45 bp UCP2 gene in the male group showed that II genotype and I allele significantly increase the risk of obesity whereas for women it showed that the DI genotype and I allele lower the risk of obesity.

7. rs1800849 in UCP3 were significantly associated with prediabetes in a rural Chinese population. Overweight modified the effect of rs660339 of UCP2 on type 2 diabetes. These findings suggested that rs1800849 in UCP3 and rs660339 in UCP2 might play an important role in the incidence and development of type 2 diabetes.

8. Data do not support the role of variants in UCP2 as a monogenic cause of hyperinsulinaemic hypoglycaemia.

9. Aspergillus protease-mediated mitochondrial Reactive Oxygen Species (ROS) production was associated with downregulation of uncoupling protein (UCP)-2 expression by TGF-beta-SMAD4 signaling, which may play a regulatory role in mitochondrial ROS formation during fungal protease-mediated epithelial inflammation.

10. UCP2-866 G/A polymorphism is associated with obesity.

11. Dats suggest that UCP2 levels in peripheral blood mononuclear cells of obese women with low REE (resting energy expenditure) are significantly lower compared to obese women with low REE and compared to normal weight women.

12. The A/A genotype was found to be an independent marker of good prognosis after adjustment for secondary variables (age, sex, glucose level, NIHSS score at baseline, complete recanalization and early neurological improvement) in a logistic regression analysis. The AA genotype of UCP2-866 may predict a better functional outcome in ischemic stroke after recanalization of proximal MCA occlusion.

13. UCP2 inhibits myointimal hyperplasia after vascular injury, probably through suppressing nuclear factor-kappaB-dependent smooth muscle cell proliferation and migration.

14. Study shows that the mitochondrial uncoupling protein 2 rs659366 A allele and rs660339 T allele are both related to longer leukocyte telomere in subjects without diabetes, independent of cardiovascular risk factors.

15. Evaluated association between nonalcoholic fatty liver disease (NAFLD) and single nucleotide polymorphism 866G of human uncoupling protein 2 (UCP2).

16. The present study identified a novel gene, UCP2, that influences the serum urate concentration and the risk of hyperuricemia, and the degree of association varies with gender and BMI levels.

17. UCP2 regulates the activity of SIRT3 through sensing the energy level and, in turn, maintaining the mitochondrial steady state, which demonstrates a cytoprotective effect on ischemia-reperfusion injury.

18. UCP2 is a key mediator of hypoxia-triggered chemoresistance in non-small cell lung cancer cells via repression of peroxisome proliferator-activated receptor gamma.

19. Results here presented suggest that UCP variability has different pleiotropic effects, by affecting both telomere length and glucose homeostasis, likely through an influence on energy metabolism and stress response

20. UCP2 expression is associated with weight loss after hypocaloric diet intervention.

Mouse (Murine) Uncoupling Protein 2 (Mitochondrial, Proton Carrier) (UCP2) interaction partners

1. The results imply that UCP2 facilitates glutamine utilization as an energetic fuel source, thereby providing metabolic flexibility during glucose shortage.

2. Uncoupling protein 2 (UCP2) involves immune response, regulation of oxidative stress, and maintenance of mitochondrial membrane potential as well as energy production. UCP2 drives septic cardiac dysfunction and that the targeted induction of UCP2-mediated autophagy may have important therapeutic potential.

3. Study data indicate that UCP2 induction in melanoma cells blocks the immunosuppressive feature of the tumor microenvironment by shifting the cytokine milieu in an interferon regulatory factor 5-dependent manner, leading to engagement of the conventional type 1 dendritic cell- and CD8+ T cell-dependent anti-tumor immune cycle, and prolonged survival in mouse B16 melanoma model.

4. UCP2 expression correlates with the extent of lymphocytes invasion in spinal cord and is antigen-independent. The maximum of UCP2 expression coincides with the peak of the active experimental autoimmune encephalomyelitis.

5. Here, the authors report that mice deficient in the mitochondrial uncoupling protein 2 gene (Ucp2(-/-)) spontaneously developed Polycystic liver diseases when they were over 12 months old.

6. UCP2 regulates daily rhythms of insulin secretion in MIN6 cells and isolated islets from male mice.

7. Study provides evidence that UCP2 plays a protecting role against LPS by regulating the balance between autophagy and apoptosis of cardiomyocytes, and by which mechanisms, it may contribute to homeostasis of cardiac function and cardiomyocytes activity.

8. UCP2 inhibits myointimal hyperplasia after vascular injury, probably through suppressing nuclear factor-kappaB-dependent smooth muscle cell proliferation and migration.

9. Upregulation of UCP2 conferred protective effects to the stressed beta-cell through mechanisms not directly associated with superoxide production.

10. UCP2-dependent modulations have a major impact on cardiac electrophysiology.

11. UCP2 regulates embryonic neurogenesis through reactive oxygen species-mediated Yap alternation, thus shedding new sight on mitochondrial metabolism involved in embryonic neurogenesis.

12. Data demonstrate that UCP2 controls pancreas development through the ROS-AKT signaling pathway.

13. UCP2 has two glycine-rich motifs, motif 1: EGIRGLWKG (170-178) and a Walker A-like motif 2: EGPRAFYKG (264-272). These motifs seem to be important for the function of UCP2. UCP2/K177E- or UCP2/G174L-expressed cells did not induce enlarged cell shapes. UCP2/K177E and UCP2/G174L produced functional incompetence of the glycine-rich motif 1. Senescent-like cells significantly decreased the mitochondrial membrane potentials.

14. our findings reveal that UCP2 regulates inflammation responses in astrocytes and plays an important role in the pathogenesis of depression and that UCP2 may be a promising therapeutic target for depression.

15. These results suggest that Leishmania exploits A20 and UCP2 to impair inflammasome activation for disease propagation

16. attenuates renal ischemia-reperfusion injury, probably by reducing cell apoptosis through protection of autophagy

17. UCP-2 prevents angiotensin-II-induced abdominal aortic aneurysm in apolipoprotein E-knockout mice via antioxidant and antiapoptotic activities.

18. This study demonstrating a FABP4-UCP2 axis with the potential to modulate the microglial inflammatory response.

19. The miR-133a-UCP2 pathway participates in inflammatory bowel disease (IBD) by altering downstream inflammation, oxidative stress and markers of energy metabolism, which provides novel clues and potential therapeutic targets for IBD.

20. PPARgamma inhibited PDGF-BB-induced ROS in VSMCs by upregulating UCP2 expression.

Pig (Porcine) Uncoupling Protein 2 (Mitochondrial, Proton Carrier) (UCP2) interaction partners

1. Despite patent grafts, revascularized hibernating myocardium demonstrates a submaximal response to dobutamine infusion and increased mitochondrial UCP-2 expression.

2. Seven deletion polymorphisms were covered in introns of linkage genes of UCP2 and UCP3, showing that UCPs have conservation and genetic reliability.

3. The in vivo data indicate that beta-adrenergic agonists may function in regulating UCP2 and UCP3 expression in selected muscles.

Cow (Bovine) Uncoupling Protein 2 (Mitochondrial, Proton Carrier) (UCP2) interaction partners

1. UCPs do have uncoupling properties when expressed in mitochondria but that uncoupling by UCP1 or UCP2 does not prevent acute substrate-driven endothelial cell superoxide as effluxed from mitochondria respiring in vitro.

2. A study evaluating the relationships of uncoupling protein 2 and 3 expression, SNP of mitochondrial DNA, and residual feed intake (RFI) in Angus steers selected to have high or low RFI is presented.

3. The effect of single nucleotide polymorphisms in 6 genes and their associations with production factors in beef cattle are reported.

4. These results suggest that UCP2 play an important role of lipid and energy metabolism in mammary epithelial cells.